Bibliography
Perez, E. E., Wang, J., Miller, J. C., Jouvenot, Y., Kim, K. A., Liu, O., Wang, N., Lee, G., Bartsevich, V. V., Lee, Y.-L., Guschin, D. Y., Rupniewski, I., Waite, A. J., Carpenito, C., Carroll, R. G., S Orange, J., Urnov, F. D., Rebar, E. J., Ando, D., ⦠June, C. H. (2008). Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nature Biotechnology, 26(7), 808â816.
Authors
23
- Elena E Perez (first)
- Jianbin Wang (additional)
- Jeffrey C Miller (additional)
- Yann Jouvenot (additional)
- Kenneth A Kim (additional)
- Olga Liu (additional)
- Nathaniel Wang (additional)
- Gary Lee (additional)
- Victor V Bartsevich (additional)
- Ya-Li Lee (additional)
- Dmitry Y Guschin (additional)
- Igor Rupniewski (additional)
- Adam J Waite (additional)
- Carmine Carpenito (additional)
- Richard G Carroll (additional)
- Jordan S Orange (additional)
- Fyodor D Urnov (additional)
- Edward J Rebar (additional)
- Dale Ando (additional)
- Philip D Gregory (additional)
- James L Riley (additional)
- Michael C Holmes (additional)
- Carl H June (additional)
References
51
Referenced
851
-
Deng, H.K. et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381, 661–666 (1996).
(
10.1038/381661a0
) / Nature by HK Deng (1996) -
Alkhatib, G. et al. Cc Ckrs: A Rantes, Mip-1 Alpha, Mip-1 Beta Receptor As A Fusion Cofactor for Macrophage-Tropic HIV-1. Science 272, 1955–1958 (1996).
(
10.1126/science.272.5270.1955
) / Science by G Alkhatib (1996) -
Liu, R. et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86, 367–377 (1996).
(
10.1016/S0092-8674(00)80110-5
) / Cell by R Liu (1996) -
Samson, M. et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382, 722–725 (1996).
(
10.1038/382722a0
) / Nature by M Samson (1996) -
Huang, Y.X. et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat. Med. 2, 1240–1243 (1996).
(
10.1038/nm1196-1240
) / Nat. Med. by YX Huang (1996) -
Lederman, M.M. et al. Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5. Science 306, 485–487 (2004).
(
10.1126/science.1099288
) / Science by MM Lederman (2004) -
Mosier, D.E. et al. Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants. J. Virol. 73, 3544–3550 (1999).
(
10.1128/JVI.73.5.3544-3550.1999
) / J. Virol. by DE Mosier (1999) -
Fatkenheuer, G. et al. Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1. Nat. Med. 11, 1170–1172 (2005).
(
10.1038/nm1319
) / Nat. Med. by G Fatkenheuer (2005) -
Kuhmann, S.E. et al. Genetic and phenotypic analyses of human immunodeficiency virus type 1 escape from a small-molecule CCR5 inhibitor. J. Virol. 78, 2790–2807 (2004).
(
10.1128/JVI.78.6.2790-2807.2004
) / J. Virol. by SE Kuhmann (2004) -
Abad, J.L. et al. Novel interfering bifunctional molecules against the CCR5 coreceptor are efficient inhibitors of HIV-1 infection. Mol. Ther. 8, 475–484 (2003).
(
10.1016/S1525-0016(03)00202-8
) / Mol. Ther. by JL Abad (2003) -
Bai, J.R. et al. Characterization of anti-CCR5 ribozyme-transduced CD34(+) hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo. Mol. Ther. 1, 244–254 (2000).
(
10.1006/mthe.2000.0038
) / Mol. Ther. by JR Bai (2000) -
Barassi, C. et al. Induction of murine mucosal CCR5-reactive antibodies as an anti-human immunodeficiency virus strategy. J. Virol. 79, 6848–6858 (2005).
(
10.1128/JVI.79.11.6848-6858.2005
) / J. Virol. by C Barassi (2005) -
Levine, B.L. et al. Adoptive transfer of costimulated CD4(+) T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection. Nat. Med. 8, 47–53 (2002).
(
10.1038/nm0102-47
) / Nat. Med. by BL Levine (2002) -
Qin, X.F., An, D.S., Chen, I.S.Y. & Baltimore, D. Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc. Natl. Acad. Sci. USA 100, 183–188 (2003).
(
10.1073/pnas.232688199
) / Proc. Natl. Acad. Sci. USA by XF Qin (2003) -
Steinberger, P., Andris-Widhopf, J., Buhler, B., Torbett, B.E. & Barbas, C.F. Functional deletion of the CCR5 receptor by intracellular immunization produces cells that are refractory to CCR5-dependent HIV-1 infection and cell fusion. Proc. Natl. Acad. Sci. USA 97, 805–810 (2000).
(
10.1073/pnas.97.2.805
) / Proc. Natl. Acad. Sci. USA by P Steinberger (2000) -
Urnov, F.D. et al. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 435, 646–651 (2005).
(
10.1038/nature03556
) / Nature by FD Urnov (2005) -
Moore, M., Choo, Y. & Klug, A. Design of polyzinc finger peptides with structured linkers. Proc. Natl. Acad. Sci. USA 98, 1432–1436 (2001).
(
10.1073/pnas.98.4.1432
) / Proc. Natl. Acad. Sci. USA by M Moore (2001) -
Jamieson, A.C., Miller, J.C. & Pabo, C.O. Drug discovery with engineered zinc-finger proteins. Nat. Rev. Drug Discov. 2, 361–368 (2003).
(
10.1038/nrd1087
) / Nat. Rev. Drug Discov. by AC Jamieson (2003) -
Smith, J. et al. Requirements for double-strand cleavage by chimeric restriction enzymes with zinc finger DNA-recognition domains. Nucleic Acids Res. 28, 3361–3369 (2000).
(
10.1093/nar/28.17.3361
) / Nucleic Acids Res. by J Smith (2000) -
Bibikova, M., Golic, M., Golic, K.G. & Carroll, D. Targeted chromosomal cleavage and mutagenesis in Drosophila using zinc-finger nucleases. Genetics 161, 1169–1175 (2002).
(
10.1093/genetics/161.3.1169
) / Genetics by M Bibikova (2002) -
Lloyd, A., Plaisier, C.L., Carroll, D. & Drews, G.N. Targeted mutagenesis using zinc-finger nucleases in Arabidopsis . Proc. Natl. Acad. Sci. USA 102, 2232–2237 (2005).
(
10.1073/pnas.0409339102
) / Proc. Natl. Acad. Sci. USA by A Lloyd (2005) -
Jasin, M. Genetic manipulation of genomes with rare-cutting endonucleases. Trends Genet. 12, 224–228 (1996).
(
10.1016/0168-9525(96)10019-6
) / Trends Genet. by M Jasin (1996) -
Valerie, K. & Povirk, L.F. Regulation and mechanisms of mammalian double-strand break repair. Oncogene 22, 5792–5812 (2003).
(
10.1038/sj.onc.1206679
) / Oncogene by K Valerie (2003) -
Morner, A. et al. Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage. J. Virol. 73, 2343–2349 (1999).
(
10.1128/JVI.73.3.2343-2349.1999
) / J. Virol. by A Morner (1999) -
Schroers, R. et al. Gene transfer into human T lymphocytes and natural killer cells by Ad5/F35 chimeric adenoviral vectors. Exp. Hematol. 32, 536–546 (2004).
(
10.1016/j.exphem.2004.03.010
) / Exp. Hematol. by R Schroers (2004) -
Hung, C.S., Vander Heyden, N. & Ratner, L. Analysis of the critical domain in the V3 loop of human immunodeficiency virus type 1 gp120 involved in CCR5 utilization. J. Virol. 73, 8216–8226 (1999).
(
10.1128/JVI.73.10.8216-8226.1999
) / J. Virol. by CS Hung (1999) -
Bibikova, M. et al. Stimulation of homologous recombination through targeted cleavage by chimeric nucleases. Mol. Cell. Biol. 21, 289–297 (2001).
(
10.1128/MCB.21.1.289-297.2001
) / Mol. Cell. Biol. by M Bibikova (2001) -
Bitinaite, J., Wah, D.A., Aggarwal, A.K. & Schildkraut, I. FokI dimerization is required for DNA cleavage. Proc. Natl. Acad. Sci. USA 95, 10570–10575 (1998).
(
10.1073/pnas.95.18.10570
) / Proc. Natl. Acad. Sci. USA by J Bitinaite (1998) -
Schultz, L.B., Chehab, N.H., Malikzay, A. & Halazonetis, T.D. p53 Binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks. J. Cell Biol. 151, 1381–1390 (2000).
(
10.1083/jcb.151.7.1381
) / J. Cell Biol. by LB Schultz (2000) -
Thiriet, C. & Hayes, J.J. Chromatin in need of a fix: Phosphorylation of H2AX connects chromatin to DNA repair. Mol. Cell 18, 617–622 (2005).
(
10.1016/j.molcel.2005.05.008
) / Mol. Cell by C Thiriet (2005) -
Tsukuda, T., Fleming, A.B., Nickoloff, J.A. & Osley, M.A. Chromatin remodelling at a DNA double-strand break site in Saccharomyces cerevisiae . Nature 438, 379–383 (2005).
(
10.1038/nature04148
) / Nature by T Tsukuda (2005) -
Peters, W., Dupuis, M. & Charo, I.F. A mechanism for the impaired IFN-gamma production in C–C chemokine receptor 2 (CCR2) knockout mice: Role of CCR2 in linking the innate and adaptive immune responses. J. Immunol. 165, 7072–7077 (2000).
(
10.4049/jimmunol.165.12.7072
) / J. Immunol. by W Peters (2000) -
Smith, M.W. et al. CCR2 chemokine receptor and AIDS progression. Nat. Med. 3, 1052–1053 (1997).
(
10.1038/nm1097-1052c
) / Nat. Med. by MW Smith (1997) -
Margulies, M. et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature 437, 376–380 (2005).
(
10.1038/nature03959
) / Nature by M Margulies (2005) -
Watanabe, S. et al. Hematopoietic stem cell-engrafted NOD/SCID/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses. Blood 109, 212–218 (2007).
(
10.1182/blood-2006-04-017681
) / Blood by S Watanabe (2007) -
An, D.S. et al. Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates. Proc. Natl. Acad. Sci. USA 104, 13110–13115 (2007).
(
10.1073/pnas.0705474104
) / Proc. Natl. Acad. Sci. USA by DS An (2007) -
Trkola, A. et al. HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use. Proc. Natl. Acad. Sci. USA 99, 395–400 (2002).
(
10.1073/pnas.012519099
) / Proc. Natl. Acad. Sci. USA by A Trkola (2002) -
Rossi, J.J., June, C.H. & Kohn, D.B. Genetic therapies against HIV. Nat. Biotechnol. 25, 1444–1454 (2007).
(
10.1038/nbt1367
) / Nat. Biotechnol. by JJ Rossi (2007) -
Levine, B.L. et al. Gene transfer in humans using a conditionally replicating lentiviral vector. Proc. Natl. Acad. Sci. USA 103, 17372–17377 (2006).
(
10.1073/pnas.0608138103
) / Proc. Natl. Acad. Sci. USA by BL Levine (2006) -
Sallusto, F., Lenig, D., Forster, R., Lipp, M. & Lanzavecchia, A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401, 708–712 (1999).
(
10.1038/44385
) / Nature by F Sallusto (1999) -
Zhang, Y., Joe, G., Hexner, E., Zhu, J. & Emerson, S.G. Host-reactive CD8(+) memory stem cells in graft-versus-host disease. Nat. Med. 11, 1299–1305 (2005).
(
10.1038/nm1326
) / Nat. Med. by Y Zhang (2005) -
Lombardo, A. et al. Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat. Biotechnol. 25, 1298–1306 (2007).
(
10.1038/nbt1353
) / Nat. Biotechnol. by A Lombardo (2007) -
Isalan, M., Klug, A. & Choo, Y. A rapid, generally applicable method to engineer zinc fingers illustrated by targeting the HIV-1 promoter. Nat. Biotechnol. 19, 656–660 (2001).
(
10.1038/90264
) / Nat. Biotechnol. by M Isalan (2001) -
Isalan, M. & Choo, Y. Rapid, high-throughput engineering of sequence-specific zinc finger DNA-binding proteins. Methods Enzymol. 340, 593–609 (2001).
(
10.1016/S0076-6879(01)40444-7
) / Methods Enzymol. by M Isalan (2001) -
Bibikova, M., Beumer, K., Trautman, J.K. & Carroll, D. Enhancing gene targeting with designed zinc finger nucleases. Science 300, 764 (2003).
(
10.1126/science.1079512
) / Science by M Bibikova (2003) -
Porteus, M.H. & Baltimore, D. Chimeric nucleases stimulate gene targeting in human cells. Science 300, 763 (2003).
(
10.1126/science.1078395
) / Science by MH Porteus (2003) -
Smith, J., Berg, J.M. & Chandrasegaran, S. A detailed study of the substrate specificity of a chimeric restriction enzyme. Nucleic Acids Res. 27, 674–681 (1999).
(
10.1093/nar/27.2.674
) / Nucleic Acids Res. by J Smith (1999) -
Miller, J.C. et al. An improved zinc-finger nuclease architecture for highly specific genome editing. Nat. Biotechnol. 25, 778–785 (2007).
(
10.1038/nbt1319
) / Nat. Biotechnol. by JC Miller (2007) -
Nilsson, M. et al. Development of an adenoviral vector system with adenovirus serotype 35 tropism; efficient transient gene transfer into primary malignant hematopoietic cells. J. Gene Med. 6, 631–641 (2004).
(
10.1002/jgm.543
) / J. Gene Med. by M Nilsson (2004) -
Lusso, P. et al. Growth of macrophage-tropic and primary human-immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1. J. Virol. 69, 3712–3720 (1995).
(
10.1128/JVI.69.6.3712-3720.1995
) / J. Virol. by P Lusso (1995) -
Morner, A. et al. Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage. J. Virol. 73, 2343–2349 (1999).
(
10.1128/JVI.73.3.2343-2349.1999
) / J. Virol. by A Morner (1999)
Dates
Type | When |
---|---|
Created | 17 years, 2 months ago (June 29, 2008, 1:07 p.m.) |
Deposited | 2 years, 3 months ago (May 18, 2023, 3:55 p.m.) |
Indexed | 1 week ago (Aug. 31, 2025, 6:03 a.m.) |
Issued | 17 years, 2 months ago (June 29, 2008) |
Published | 17 years, 2 months ago (June 29, 2008) |
Published Online | 17 years, 2 months ago (June 29, 2008) |
Published Print | 17 years, 2 months ago (July 1, 2008) |
@article{Perez_2008, title={Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases}, volume={26}, ISSN={1546-1696}, url={http://dx.doi.org/10.1038/nbt1410}, DOI={10.1038/nbt1410}, number={7}, journal={Nature Biotechnology}, publisher={Springer Science and Business Media LLC}, author={Perez, Elena E and Wang, Jianbin and Miller, Jeffrey C and Jouvenot, Yann and Kim, Kenneth A and Liu, Olga and Wang, Nathaniel and Lee, Gary and Bartsevich, Victor V and Lee, Ya-Li and Guschin, Dmitry Y and Rupniewski, Igor and Waite, Adam J and Carpenito, Carmine and Carroll, Richard G and S Orange, Jordan and Urnov, Fyodor D and Rebar, Edward J and Ando, Dale and Gregory, Philip D and Riley, James L and Holmes, Michael C and June, Carl H}, year={2008}, month=jun, pages={808–816} }